Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 2,500 shares at $36.17 ($90K) on 2014-04-22, disclosed to the SEC on 2014-04-24.
Scheduled sale ($90k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.75 | 1,800 | $64K | 71.8% |
| 2 | $36.17 | 700 | $25K | 28.2% |
| Total | $35.87 avg | 2,500 | $90K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |